First Midwest Bank Trust Division’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-10,645
Closed -$808K – 477
2016
Q2
$808K Buy
10,645
+3,403
+47% +$248K 0.1% 230
2016
Q1
$502K Sell
7,242
-20
-0.3% -$1.2K 0.07% 250
2015
Q4
$437K Sell
7,262
-260
-3% -$15.6K 0.07% 230
2015
Q3
$407K Buy
7,522
+1,160
+18% +$67.6K 0.07% 246
2015
Q2
$370K Hold
6,362
– – 0.06% 293
2015
Q1
$383K Buy
6,362
+70
+1% +$3.73K 0.06% 291
2014
Q4
$335K Sell
6,292
-190
-3% -$9.5K 0.05% 315
2014
Q3
$290K Buy
6,482
+140
+2% +$5.95K 0.05% 339
2014
Q2
$268K Buy
6,342
+230
+4% +$9.85K 0.04% 364
2014
Q1
$269K Buy
6,112
+30
+0.5% +$1.41K 0.04% 346
2013
Q4
$298K Buy
6,082
+3,101
+104% +$145K 0.05% 296
2013
Q3
$245K Sell
2,981
-2,981
-50% -$114K 0.05% 306
2013
Q2
$209K Buy
+5,962
New +$196K 0.04% 317

Other funds holding WST

First Midwest Bank Trust Division's WST Position: Q3 2016 in Review

First Midwest Bank Trust Division sold out of West Pharmaceutical (WST) in Q3 2016, closing a stake of 10,645 shares — an estimated $808K sold.

First Midwest Bank Trust Division first reported a position in WST in Q2 2013 and held it in 13 quarters. The position peaked at $808K in Q2 2016. 280 funds tracked by Wall St. Rank hold WST as of Q3 2016.

  • First Midwest Bank Trust Division reported no remaining West Pharmaceutical position as of Q3 2016 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 10,645 West Pharmaceutical shares in Q3 2016, an estimated $808K.
  • First Midwest Bank Trust Division first reported a position in West Pharmaceutical in Q2 2013 and held it in 13 quarters.
  • First Midwest Bank Trust Division's West Pharmaceutical position peaked at $808K in Q2 2016.
  • 280 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2016.

Based on First Midwest Bank Trust Division's 13F filing for Q3 2016, filed 7 Nov 2016.